TNFRSF18 and cancer: To test this hypothesis, we examined the correlation between baseline GITR expression levels on CD3+, CD4+, and CD8+ T cells (D0) and the cytotoxic activity of WIOG-expanded TILs on day 14 (D14) against autologous primary cancer cells.